CR

Chenchala Rami Reddy

Director Director DIN 01477528
DIN 01477528 First appointment Dec 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Dec 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Chenchala Rami Reddy

Data last updated:

Chenchala Rami Reddy has 19 years in corporate governance. Formerly with 1 company, such as Lograns Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01477528
Primary Designation Director
First Appointment 27 Dec 2006
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lograns Pharma Private Limited U24232TG2006PTC052130
Director27 Dec 20062006₹45.5 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lograns Pharma Private Limited
Premium access

Shareholding and investment profile for Chenchala Rami Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chenchala Rami Reddy

Chenchala Rami Reddy has 19 years in corporate governance. Formerly with 1 company, such as Lograns Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Chenchala Rami Reddy has expertise in General Business.

Chenchala Rami Reddy has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available